US Broker Ratings

Embecta Corp. (EMBC) Stock Analysis: Exploring a High Dividend Yield with a 14.29% Upside Potential

Embecta Corp. (NASDAQ: EMBC) is a notable player in the healthcare sector, specifically within the medical instruments and supplies industry. Based in Parsippany, New Jersey, Embecta..

Delcath Systems, Inc. (DCTH) Stock Analysis: A Promising 52.24% Potential Upside for Healthcare Investors

Delcath Systems, Inc. (NASDAQ: DCTH) presents a captivating opportunity for investors focused on the healthcare sector, particularly in the niche of medical devices. With a market..

Kura Oncology, Inc. (KURA) Stock Analysis: Exploring a 235.85% Potential Upside in the Biotechnology Sector

For investors with a keen eye on the biotechnology sector, Kura Oncology, Inc. (KURA) presents a compelling opportunity. Positioned as a clinical-stage biopharmaceutical company, Kura Oncology..

Bicara Therapeutics Inc. (BCAX) Investor Outlook: Tapping into a 14% Upside with Innovative Biotech Solutions

Bicara Therapeutics Inc. (NASDAQ: BCAX), the Boston-based clinical-stage biopharmaceutical company, is making waves in the biotechnology industry with its promising approach to cancer treatment. Specializing in..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Strong Revenue Growth and High ROE Offer Intriguing Investment Prospects

Theravance Biopharma, Inc. (NASDAQ: TBPH), a prominent player in the biotechnology sector, is captivating investor attention with its robust revenue growth and an impressive return on..

Anavex Life Sciences Corp. (AVXL) Stock Analysis: Exploring a Potential 509% Upside in Biotech

Anavex Life Sciences Corp. (NASDAQ: AVXL) is catching the attention of investors with its intriguing potential upside in the biotechnology sector. With a market capitalization of..

Zenas BioPharma, Inc. (ZBIO): Investor Outlook on a Potential 35% Upside

Zenas BioPharma, Inc. (NASDAQ: ZBIO), a dynamic player in the biotechnology sector, has been capturing investor attention with its promising portfolio of immunology-based therapies. With a..

Bioventus Inc. (BVS) Stock Analysis: Healthcare Innovator with 5.87% Upside Potential

Bioventus Inc. (BVS), a key player in the healthcare sector, is making notable strides in the medical device industry with a focus on innovative pain relief..

Valneva SE (VALN) Stock Analysis: Can Its 135% Upside Potential Attract Investors?

Valneva SE (NASDAQ: VALN), a prominent player in the biotechnology sector with a focus on developing vaccines for infectious diseases, stands at a crucial juncture for..

Zymeworks Inc. (ZYME): Analyst Consensus and Potential 72% Upside Make This Biotech Stock Worth Watching

Zymeworks Inc. (NASDAQ: ZYME), a prominent player in the biotechnology sector, is capturing investor attention with its cutting-edge developments in biotherapeutics aimed at treating cancer, inflammation,..

InMode Ltd. (INMD) Stock Analysis: Evaluating Growth Potential in the Medical Device Sector

InMode Ltd. (NASDAQ: INMD), an Israel-based medical device company, has carved out a niche in the healthcare sector with its innovative approach to minimally invasive aesthetic..

iRadimed Corporation (IRMD) Stock Analysis: A Look at Its 29% Upside Potential

For investors seeking opportunities in the dynamic healthcare sector, iRadimed Corporation (IRMD) presents an intriguing proposition. As a leading provider of MRI-compatible medical devices, the company’s..

Spyre Therapeutics, Inc. (SYRE) Investor Outlook: Promising Biotech with 4.98% Upside Potential

Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company, is making waves in the healthcare sector with its innovative approach to treating inflammatory bowel disease (IBD)..

Claritev Corporation (CTEV) Stock Analysis: Analyzing a 40% Potential Upside in the Healthcare Sector

Claritev Corporation (NASDAQ: CTEV), a key player in the healthcare sector’s health information services industry, is capturing investor attention with a notable 40.34% potential upside based..

Orthofix Medical Inc. (OFIX): Analyzing the 34.43% Potential Upside in the Medical Devices Sector

Orthofix Medical Inc. (NASDAQ: OFIX), a prominent player in the medical devices sector, is drawing investor attention with its substantial potential upside of 34.43% as projected..

Cronos Group Inc. (CRON) Stock Analysis: Navigating a 40% Revenue Growth with Investor Ratings in Focus

Cronos Group Inc. (NASDAQ: CRON), a prominent player in the cannabinoid market, is making significant waves with its dynamic business model centered around the cultivation, production,..

Upstream Bio, Inc. (UPB) Stock Analysis: A Hidden Gem in Biotechnology with a 456% Potential Upside

Upstream Bio, Inc. (NASDAQ: UPB), a promising player in the biotechnology sector, is capturing investor attention with its substantial growth potential. As a clinical-stage company focused..

Zevra Therapeutics, Inc. (ZVRA) Investor Outlook: A Biotech Stock with 113% Potential Upside

In the ever-evolving world of biotechnology, Zevra Therapeutics, Inc. (NASDAQ: ZVRA) stands out with its focus on addressing rare diseases, a market segment that often promises..

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: Navigating a Transformative Biotechnology Path with a 4.67% Upside

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is making headlines in the biotechnology sector with its ambitious approach towards developing breakthrough therapeutics for conditions that currently lack effective..

Sionna Therapeutics, Inc. (SION) Stock Analysis: Assessing the 7.24% Upside Potential Amid Innovative Cystic Fibrosis Treatments

Sionna Therapeutics, Inc. (SION) is making significant strides in the biotechnology sector, capturing the attention of investors with its promising pipeline of cystic fibrosis (CF) treatments...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds